Company research / CHE

Chemed Corp (CHE)

SEC name CHEMED CORP · CIK 0000019584 · NYSE · Services-Home Health Care Services

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Chemed Corp reported revenue of $2.53B. Revenue grew 4.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $2.60B.

Key ratios (year ended 2025-12-31)

32.5%
Gross margin (computed)
13.4%
Operating margin
10.5%
Net margin
27.1%
Return on year-end equity
4.1%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-01

Headquarters locality: Wilmington · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$2.60B$2.53B$2.43B$2.26B$2.13B$2.14B$2.08B$1.94B$1.78B$1.67B$1.58B
Cost of Revenue$1.74B$1.71B$1.58B$1.47B$1.37B$1.37B$1.38B$1.32B$1.23B$1.15B$1.12B
Gross Profit (computed)$859.31M$823.18M$854.35M$798.82M$765.09M$769.80M$701.39M$617.43M$555.00M$516.19M$461.45M
Operating Income$349.19M$338.25M$366.49M$340.57M$343.50M$343.04M$389.68M$257.38M$243.63M$113.03M$178.75M
Depreciation & Amortization$66.42M$64.84M$63.05M$60.87M$59.17M$59.05M$56.58M$45.20M$38.86M$35.62M$34.64M
EBITDA$415.61M$403.09M$429.54M$401.43M$402.67M$402.09M$446.26M$302.58M$282.50M$148.66M$213.39M
Net Income$274.99M$265.24M$302.00M$272.51M$249.62M$268.55M$319.47M$219.92M$205.54M$98.18M$108.74M
EPS (Diluted)n/a$18.34$19.89$17.93$16.53$16.85$19.48$13.31$12.23$5.86$6.48
Total Assets$1.58B$1.54B$1.67B$1.67B$1.44B$1.34B$1.43B$1.27B$975.53M$920.03M$880.06M
Total Liabilities$749.08M$558.78M$549.58M$560.22M$643.30M$719.45M$533.71M$541.71M$384.19M$379.67M$355.96M
Long-Term Debtn/an/an/an/a$97.50M$185.00Mn/a$90.00M$89.20M$101.20M$108.75M
Shareholders' Equity$830.51M$979.40M$1.12B$1.11B$798.72M$623.27M$901.20M$726.61M$591.33M$540.35M$524.10M
Cash & Equivalents$40.22M$74.52M$178.35M$263.96M$74.13M$32.90M$162.68M$6.16M$4.83M$11.12M$15.31M
Operating Cash Flow$389.95M$388.27M$417.50M$330.30M$309.89M$308.60M$489.29M$301.25M$287.14M$162.50M$135.39M
Capital Expenditures$66.35M$62.80M$49.53M$56.85M$57.33M$58.67M$58.83M$53.02M$52.87M$64.30M$39.77M
Free Cash Flow$323.61M$325.48M$367.97M$273.44M$252.56M$249.92M$430.46M$248.23M$234.27M$98.19M$95.62M
Share Repurchases$642.85M$431.50M$361.39M$67.70M$114.52M$576.04M$175.59M$92.63M$158.88M$94.64M$102.31M
Dividends Paid$33.20M$31.70M$27.09M$23.50M$22.02M$22.02M$21.08M$19.79M$18.66M$17.37M$16.44M
Dividends Per Sharen/a$2.20$1.80$1.56$1.48$1.40$1.32$1.24$1.16$1.08$1.00
Weighted Average Diluted Sharesn/a14.46M15.19M15.20M15.10M15.94M16.40M16.53M16.80M16.74M16.79M
EPS (Basic)n/a$18.42$20.10$18.11$16.72$17.14$20.02$13.77$12.80$6.11$6.64

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView